Cel-Sci
Cel-Sci posts net loss of $1.3 million
Published in Lab Business Week, September 24th, 2006
The company's net loss for the quarter ending June 30, 2006 was $1,294,041 versus a net loss of $653,786 during the same quarter in 2005. The company's net loss for the 9 months ended June 30, 2006 was $3,622,239 versus a net loss of $3,032,669 during the same 9 months in 2005.
The losses reported in 2005 were affected by substantial gains on derivative instruments of $319,570 for the 3 month period and $211,715 for the 9 month period. In 2006 the corresponding periods had much smaller gains on derivative instruments of $1,615 and $13,130 respectively.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2006-09-24)
More Articles from Lab Business Week
- 4-Antibody
4-Antibody closes CHF 6 million series A financing, appoints Sijmen de Vries as CEO - Ablynx
Ablynx completes EUR 40 million series C financing - Adams Respiratory Therapeutics
Adams Respiratory Therapeutics reports 35% increase in net sales - Affymetrix
Affymetrix announces update regarding stock option grants - Arrowhead Research
Arrowhead names Paul McDonnel as VP, finance and accounting - Arrowhead Research
Arrowhead raises additional capital from institutional shareholders - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
